Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients

Wen Li(First Affiliated Hospital of Xi'an Jiaotong University), Huaidong Cheng(Third Affiliated Hospital of Southern Medical University), Yanyan Jing(Tianjin University of Traditional Chinese Medicine), Xu Duan(Anhui Medical University), Xiangxiang Yin(Central South University), Lulian Pang(Anhui Medical University), Junxu Wu(Anhui Medical University), Ziran Bi(Anhui Medical University)
Frontiers in Oncology
July 25, 2022
Cited by 5


Related Papers